Tokyo Tape
Sign in
← Olympus

Quarterly report · Q3

7733.TEDINET S100Q5QA
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥641.5bn2022-04-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥224.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥750.1bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥547.2bn2021-04-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥187.1bn2021-10-01 → 2021-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥142.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥49.0bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥102.2bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥31.6bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥139.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥50.0bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥141.7bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥97.0bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥28.6bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥108.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥115.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥87.7bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥25.3bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥108.4bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥87.8bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥25.3bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥1.39Tat 2022-12-31Cons.Assets IFRS
Total assets¥1.36Tat 2022-03-31Cons.Assets IFRS
Total assets¥1.29Tat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥787.0bnat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥846.6bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥605.6bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥480.3bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥395.5bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥604.5bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥510.2bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥479.1bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥175.7bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥211.3bnat 2022-12-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥302.6bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥275.1bnat 2021-12-31Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥54.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥169.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥115.3bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥37.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥71.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥57.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥112.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥9.3bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥85.122022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.642022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥90.222021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥68.192021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥19.662021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥85.042022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.62022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥90.172021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥68.162021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥19.652021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio43.4%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.1%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥15.3bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥110.7bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-12-31−¥917m
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥48.1bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥157.9bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥31.7bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2021-04-01 → 2021-12-31¥91.6bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2021-04-01 → 2021-12-31−¥1.5bn
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2021-04-01 → 2021-12-31¥43.8bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥134.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 734
ItemContextValueUnit
Capital surplus IFRSCurrentQuarterInstant91903000000JPY
Treasury shares IFRSPrior1YearInstant-45589000000JPY
Treasury shares IFRSCurrentQuarterInstant-55291000000JPY
Other components of equity IFRSPrior1YearInstant34818000000JPY
Other components of equity IFRSCurrentQuarterInstant68212000000JPY
Other components of capital related to the disposal group held for sale equity IFRSPrior1YearInstant－JPY
Other components of capital related to the disposal group held for sale equity IFRSCurrentQuarterInstant2427000000JPY
Retained earnings IFRSPrior1YearInstant305057000000JPY
Retained earnings IFRSCurrentQuarterInstant372574000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant510168000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant604468000000JPY
Non controlling interests IFRSPrior1YearInstant1194000000JPY
Non controlling interests IFRSCurrentQuarterInstant1120000000JPY
Equity IFRSPrior1YearInstant511362000000JPY
Equity IFRSCurrentQuarterInstant605588000000JPY
Liabilities and equity IFRSPrior1YearInstant1357999000000JPY
Liabilities and equity IFRSCurrentQuarterInstant1392608000000JPY
Net sales IFRSPrior1YTDDuration547184000000JPY
Net sales IFRSCurrentYTDDuration641545000000JPY
Cost of sales IFRSPrior1YTDDuration181117000000JPY
Cost of sales IFRSCurrentYTDDuration207821000000JPY
Gross profit IFRSPrior1YTDDuration366067000000JPY
Gross profit IFRSCurrentYTDDuration433724000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration259112000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration306085000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration577000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration490000000JPY
Other income IFRSPrior1YTDDuration8043000000JPY
Other income IFRSCurrentYTDDuration21911000000JPY
Other expenses IFRSPrior1YTDDuration13344000000JPY
Other expenses IFRSCurrentYTDDuration7468000000JPY
Operating profit loss IFRSPrior1YTDDuration102231000000JPY
Operating profit loss IFRSCurrentYTDDuration142572000000JPY
Finance income IFRSPrior1YTDDuration970000000JPY
Finance income IFRSCurrentYTDDuration2983000000JPY
Finance costs IFRSPrior1YTDDuration6191000000JPY
Finance costs IFRSCurrentYTDDuration6185000000JPY
Profit loss before tax IFRSPrior1YTDDuration97010000000JPY
Profit loss before tax IFRSCurrentYTDDuration139370000000JPY
Income tax expense IFRSPrior1YTDDuration14043000000JPY
Income tax expense IFRSCurrentYTDDuration33751000000JPY
Profit loss from continuing operations IFRSPrior1YTDDuration82967000000JPY
Profit loss from continuing operations IFRSCurrentYTDDuration105619000000JPY
Profit loss from discontinued operations IFRSPrior1YTDDuration4882000000JPY
Profit loss from discontinued operations IFRSCurrentYTDDuration2750000000JPY
Profit loss IFRSPrior1YTDDuration87849000000JPY
Profit loss IFRSCurrentYTDDuration108369000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration87667000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration108217000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration182000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass